lymphoma
-
Health
Lymphoma Control Better Goal Than Remission
Getting lymphoplasmacytic lymphoma under control might be a better objective than complete remission, delegates heard here at the International Waldenstrom’s…
Read More » -
Health
Novel Drug Targets Lymphoma Cells’ ‘Don’t Eat Me’ Signal
AMSTERDAM — A novel drug that targets the so-called ‘do not eat me’ signal that protects malignant tumor cells in…
Read More » -
Health
MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma
Oncogenic MYC activation promotes proliferation in Burkitt lymphoma, but also induces cell-cycle arrest and apoptosis mediated by p53, a tumor…
Read More » -
Health
FDA Approves First Chemoimmunotherapy for R/R Lymphoma Type
The US Food and Drug Administration (FDA) has granted accelerated approval to polatuzumab vedotin-piiq (Polivy, Genentech/Roche), in combination with the…
Read More » -
Health
New Lymphoma Drugs Build on BTK Inhibitor Success
The optimization of standard therapy, novel drug combinations, and new targets for Waldenstrom’s macroglobulinemia are generating excitement, said Stephen Ansell,…
Read More » -
Health
Patients With Rare Lymphoma Describe Divergent Experiences
Don Brown remembers the extreme fatigue he felt on a ski trip 17 years ago, just before a physician diagnosed…
Read More » -
Health
Revlimid Combo OK’d for Relapsed Indolent Lymphoma
The FDA approved the combination of lenalidomide (Revlimid) and rituximab (Rituxan) on Tuesday for treating relapsed or refractory follicular and…
Read More » -
Health
Model Predicts Progression Risk for Rare Type of Lymphoma
FRIDAY, May 3, 2019 — A publicly available model can identify patients with asymptomatic Waldenström macroglobulinemia (AWM) at high risk…
Read More » -
Health
J-Shaped Association Seen for BMI, Hodgkin Lymphoma
News Professional J-Shaped Association Seen for BMI, Hodgkin Lymphoma MONDAY, April 22, 2019 — There is a strong positive association…
Read More » -
Health
ITP and B-cell Lymphoma Feature in Latest BSH Guidance
GLASGOW — Recommendations on how to prevent glucocorticoid-induced osteoporosis in immune thrombocytopenia (ITP) patients receiving steroids and the optimal management…
Read More »